Ambea AB

AMBEA · Nasdaq Stockholm · Healthcare

171.00SEK −1.8%last day

Price as of 2 October 2026

The price over the past year, with dividends: +28.1%

Performance

1 month

−0.4%

1 year

+28.1%

3 years, per year

+74.6%

5 years, per year

+24.6%

Largest fall, 3 years

−54.4%

Below the peak now

−3.6%

Volatility, 1 year

32.9%

Return with dividends reinvested.

Key figures

P/E

16.8

P/B

2.6

Dividend yield

1.5%

Return on equity

+15.3%

Net margin

+4.7%

Market value

1.4 bn USD

Quality, value and trend

Where Ambea stands against every Nordic stock today. 100 is best.

Quality61

Profitability and a sound balance sheet over time. Better than 61% of Nordic stocks.

Value67

The price measured against earnings, assets and cash flow. Better than 67% of Nordic stocks.

Trend87

The price development over the past year. Better than 87% of Nordic stocks.

Combined88

Quality, value and trend together. Better than 88% of Nordic stocks.

About Ambea

Ambea AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 41,000 employees.

Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services for elderly people under the Vardaga brand; and social care for adults, children, and youth, as well as personal assistance under the Stendi brand. It also offers disability care, nursing home, home care, and rehabilitation services under the Altiden brand.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis